Charles Brunet
About Charles Brunet
Charles Brunet is the Strategy and Operations Lead at Bristol Myers Squibb in the United States, with extensive experience in quality control and stability roles across the pharmaceutical industry.
Company
Charles Brunet is currently working at Bristol Myers Squibb, a global biopharmaceutical company, in the United States. Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Charles Brunet holds the position of Strategy and Operations Lead at Bristol Myers Squibb. In this role, he leads a centralized Operational Excellence office, and serves as the Project Portfolio Management Point of Contact within the company.
Education and Expertise
Charles Brunet studied at Gordon College, where he earned a Bachelor of Science (B.S.) in Chemistry from 1993 to 1997. His background includes extensive experience in quality control, stability management, and operational excellence within the pharmaceutical industry.
Professional Background
Charles Brunet's professional journey includes roles at several notable companies. His tenure at Bristol Myers Squibb has included positions as a Senior Stability Scientist and Stability Lead. Prior to Bristol Myers Squibb, he worked at Pfizer as a Stability Specialist III and at Wyeth Biotech as a Quality Control Supervisor and Associate. He also held roles at Pharmeco Laboratories and ChemDesign Corporation, gaining broad experience in quality control.
Achievements
Charles Brunet has led significant initiatives at Bristol Myers Squibb. He played a key role in the integration of processes and systems across multiple groups, including the newly acquired Celgene. He developed an aligned trending program within the commercial Global Stability organization and introduced industry best practices through external engagement. His leadership in these areas has contributed to operational excellence within the company.